MIM# 16,55Q01 ) i s an eye disorder first clinically described by Snel12 in 1897 and then again by Kjer in 1959.* The disease has an incidence of approximately 1150,OQO,*" making it the most common form of inherited optic atrophy. Disease penetrance is nearlycomplete at 0.9k5 Kjer-type optic atrophy is suspected to be caused by diffuse, bilateral degeneration o f the retinal ganglion cell layer of the eye with ascending demyelination and loss of nerve tissue on the temporal aspect of the optic n e~e s . 3 .~
The disease is clinically characterized by an insidious onset within the first decade of life of a symmetrica1 and progressive decrease in visual acuiv, blue-yellow dyschromatopsia, and centrocecal scotomas of variable density." Therc is considerable heterogene~ty in clinical symptoms of affected individuals, including reports o f both inter-and intrafamilial phenotypic variability.3.h-8 Reduction in visual acuity ranges from mild to severe visual impairment. In addition, optic disc involvement ranges from mild temporal pallor to complete atrophy of the optic nerve. ' Various studies have been conducted to define clinical characteristics of the disease and to identify the specific gene or genes responsible for autosornal dominant optic atrophy. The OPAl gene locus was initially mapped to 3q28-qter by Eiberg et al, in 1994 by linkage analysis of three Danish families using dinucleotide repeat polymorphisms.1° Linkage to this region was also observed in four French pedigrees with autosomal dom~nant optic atrophy.'' The critical region was subsequently narrowed to the chromosome 3q28 -29 region by analysis of Cuban and British pedigrees.1?.l3 In 1947, the OPAl gene locus was further refined the to a 1.4-cM interval on chromosome 3q28-3q29 between markers D3S3669 and D3S3562 in a study of five Danish families with autosomal dominant optic arrophy.14 A founder effect of the dominant optic atrophy locus was demonstrated in a study of ~e n e t h ,~~ Medicine
Visual assessment
Each subject was examined for visual acuity, color vision, and optic disc appearance. Visual acuity in each eye was evaluated based on best-corrected Snellen visual acuity. Color vision was assessed using Ishihara plates in all individuals and quantitated by the number of color plates accurately identified. The Farnsworth-Munsell 100-Hue test was additionally administered to seven individuals. Optic disc appearances for each subject were evaluated by direct funduscopic examination. Optic disc appearances were characterized as normal, or showing pallor, andlor excavation as determined by the examiner. Subjects were classified as clinically affected if they were an "at r i s k individual greater than 6 years of age with reduced visual acuity (<20/30), color vision deficit, and optic nerve pallor. Individuals were considered "at r i s k if they were the offspring of people with definite optic atrophy and, therefore, were at 50% risk of inheriting the disease.
Statistical analysis
Visual acuity was evaluated by statistical methods including t-tests and regression analyses. Snellen acuity units were converted to the log of the minilnuln angle of resoltrtioll (logMAR units) . The logMAR of 201200 vision = log of 200120, or the log of 10 = 1. Statistical significance was set at 5%.
DNA-marker analysis
Blood samples, buccal scrapings, or both were collected from each subject. Genomic DNA was extracted from whole blood using a kit supplied by TEL-TEST, Inc. Buccal samples were processed using standard methods. Individuals were genotyped using nine polymorphic microsatellite markers on chromosome 3q28-29 overlapping the critical region of the OPAl locus: D3S2418, D3S3669, D3S1523, D3S3642, D3S2305, D3S3590, D3S3562, D3S2748, and D3S1265. All forward primers were tagged with fluorescein dye using a 5'-oligolabeling kit (Amersham Pharmacia Biotech.) with the exception of D3S2305 and D3S1265. Markers D3S2305 and D3S1265 were obtained prelabeled from the manufacturer (Research Genetics, Inc.) Polymerase chain reaction (PCR) amplification was carried out in a 25-pL final reaction volume containing of 2-6 ng genomic DNA, 20 pmol each primer, 0.2mM each dNTP, 1X PCR buffer, 1.5 mM MgCl,, and 1 U Taq DNA polymerase. Amplification was carried out for 35 cycles (95°C for 1 minute, 59-62°C for 1 minute, and at 72°C for 1 minute 30 seconds) followed by a final extension at 72OC for 7 minutes. Samples were analyzed on a 6% 6 M urea denaturing polyacrylamide gel prepared in 1X TBE. Electrophoresis was carried out at 40 W for 1-3 hours. Fragments were visualized using an FM-BIO 100 fluorescent image-scanning unit (Hitachi).
Linkage analysis
Allele information was obtained from Genome Database.lX Marker-allele frequencies were estimated from the data by means of both observed and reconstructed genotypes of founders within the pedigrees. Two-point linkage analyses were carried out under an autosomal dominant model using the software LINKAGE. Multipoint linkage analyses were performed using LINKMAP.ly The genetic map derived by Votruba et al.I5 was used to assign the order and relative genetic distances between the polymorphic markers in the multipoint analysis. Age-dependent penetrance was taken into account to allow for children who had not yet demonstrated any clinical evidence of optic atrophy. The five dependent risk classes identified were as follows: I, 0-10 years old, 0.60 ; 11, 11-20 
RESULTS

Clinical evaluation
Two central Illinois families, one of mixed Caucasian descent and the other of German ancestry, were used in a clinical and molecular study to evaluate the phenotypic and genetic heterogeneity of dominant optic atrophy. Table 1 summarizes the clinical findings of both families. In Family A, 17 individuals (1 1 M, 6 F) subjected to visual assessment had clinical findings consistent with optic atrophy with visual acuity among family members ranging from 20125 to 201800 with poor color vision in older individuals. The proband, individual III:3, was diagnosed with optic atrophy at age 17, although he admitted having visual difficulties from the age of 7 years. He attended a school for the blind and visually impaired from an early age. His recent visual acuity was 201400 OD and 201400+ OS, and his color vision was also poor (Ishihara 1/14). He had markedly pale optic discs with large optic cups. Brain and optic nerve magnetic resonance imaging was normal. His son (1V:l) age 6 years, was clinically diagnosed with optic atrophy after experiencing difficulty with his vision in the classroom setting. His visual acuity was 20160 OU; however, his color vision was normal. The youngest individual in Family A diagnosed with optic atrophy was IV:22, a 5% year old male who had failed a vision screening test administered at his school. On subsequent ophthalmological evaluation, his visual acuity was 20160 OU and optic nerve pallor was apparent. He scored 11/14 on Ishihara color vision testing.
The clinical variability and incomplete penetrance of dominant optic atrophy makes diagnosis of the disorder difficult to establish in some individuals. For example, individual II:3, a 61 year old female and obligate carrier of the OPAl gene, had normal visual acuity and moderately preserved color vision. In contrast, two individuals in Family A had an early onset of symptoms, presenting at ages 6 and 7 years. Visual impairment in individual IV:12 was difficult to interpret, given his existing diagnosis of CHARGE syndrome, a complex disorder of unknown etiology characterized by Coloboma of the eyes, Heart defects, Atresia of the choanae, Retarded growth and development, Genital hypoplasia, and Ear anomalies or hearing loss. This patient exhibited coloboma of his right optic disc, patent ductus arteriosis, a visual acuity of 20140, and normal color vision. The proband for Family B (IV:2) is a 13 year old girl with learning disabilities, dysmorphic features, subglottic hemangiomas, immunoglobulin deficiencies, and failure to thrive. Dysmorphological evaluation failed to establish a diagnosis, and karyotype and basic metabolic studies on her were normal. Her visual acuity was 20120, and funduscopic examination was normal. Although she had no visual deficits on evaluation, her family history determined that she was at risk of inheriting autosomal dominant optic atrophy. In total, seven individuals were examined in Family B, five of which were identified as affected upon visual examination (2 M, 3 F) . Visual acuity of affected individuals ranged from 20150 (IV:3) to 201400 (11:4) , and optic disc atrophy was moderate to advanced. Her sister, age 14, was found to have poor visual acuity and color vision, as well as features of optic disc atrophy.
Interestingly, vision loss among affected males was observed to be more severe than among affected females. The Student's T-test established that there was no significant difference in ages between the genders of both study groups; however, the log visual acuity between genders was statistically significant ( P = 0.02). Figure 2A depicts a scatterplot of age versus visual acuity comparing affected males to affected females. There were no statistical differences in the slopes of the linear regressions between the genders when predicting visual acuity from age, although there was still a difference in the mean visual acuity ( P < 0.05). In addition, Figures 2B and 2C present the results, including 95% prediction intervals, when a quadratic component was added to the model. This analysis increases the R' value from 0.09 for females and 0.49 for males to approxi-
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A Visual Acuity as a Function of Gender I * Female Visual Acuity I Male Visual Acuity Fig. 2 Scatterplot of age versus vlsual acuity comparing affected males and affected females. Panel A depicts linear regression of visual acuity plotted as a funct~on of age for affected females versus dffected males. Panels B and C present visual acuity data with a quadratic component added to the model. The 95% pred~ction interval for each data set 1s represented by dashed lines. Triangles denote female data; diamonds denote male ddta. mately 0.61 for both, thereby increasing the predictive ability of the model and also indicating a significant difference between genders (P < 0.001 ).
Genetic linkage and haplotype analysis
Genotyping of both families with microsatellite markers established linkage to the OPAl locus on chromosome 3q28-q29. Table 2 presents the LOD scores derived from two-point linkage analysis of Families A and B. A maximum combined LOD score of 4.68 at 8 = 0.0 was obtained with marker D3S2305. Multipoint analysis of both families generated a maximum LOD score of 5.82 positioned within the D3S2305-D3S3590 interval (Fig. 3) . The disease haplotype was reconstructed via visual inspection, assigning the most likely linkage phase by minimizing the number of recombinations within a pedigree (Figs. l a and lb) . In Family A, a recombination between markers D3S1265 and D3S2748 (IV:13, Family A) ex- Table 2 Two-~oint LOD scores using markers from chromosome 30 cluded the region telomeric of D3S2748. Individual IV:13, a female 19 years old, had no evidence of optic atrophy. Her visual acuity was 20140 OD and 20120 OS and her color vision was normal. She is presumed to be an asymptomatic carrier of disease, because she has the disease haplotype encompassing the critical region as defined in previous reports. Figure 4 summarizes conclusions derived from haplotype analysis and previous reports defining the OPAl genetic locus. It was noted that the haplotype designation for markers within the critical region of the OPAl locus differs between Family A and B. Since the distance spanning the markers examined is relatively small (1.4 cM), it is likely that genetic mutations resulting in disease manifestations in these two families arose independently of each other, and the same founder is not responsible for dominant optic atrophy in these two central Illinois pedigrees. 
DISCUSSION
This cross-section study in two families with aut~somal dominant optic atrophy show intrafamilial clinical variability and a more severe phenotype among older individuals for both color and visual acuity. Clinical features in affected individuals ranged from near normal visual acuity and relatively preserved color vision (II:3, Family A) to severe loss of vision in a 60 year old male with who was diagnosed with optic atrophy in his 20% and suffered from diabetes and strokes (II:7, Family A) ( Table  1) . Males were found to be more severely affected than funales in our families, as indicated by the log visual acuity between the genders. A more striking sex-influenced difference in disease severity was previously observed by Gorgone et al.' O In their study of 20 affected members of a single, three-generation family with dominant optic atrophy, the authors observed a bimodal distribution of disease severity. All four of the severely affected individuals were males, whereas the remaining 16 individuals ( 7 M, 9F) were asymptomatic with mild optic atrophy. No clear genetic or environmental factor has been identified that would explain this sex difference, but it could be due to the influence of epigenetic factors.
In addition to the primary disease locus on chromosome 3q28-q29, genetic heterogeneity of autosomal dominant optic atrophy recently has been demonstrated with linkage to chromosome 18.16 Molecular analysis of the two families in this study established linkage to chromosome 3q28-qter. Informative recombinations were not observed upon haplotype analysis of either pedigree examined in this study, thereby precluding further refinement of the OPA gene locus. Multipoint analysis, however, determined that the gene most likely resides in the interval flanked by markers D3S2305 and D3S3590, a finding consistent with other reports.
Despite refinement of the OPAl locus to within 400 kb of D9S1523,' the gene responsible for this disorder remains unknown. Two candidate genes have been excluded, however, through mutational and haplotype analysis. The DAGK3 gene (diacylglycerol kinase 3), predominantly expressed in the human retina," has been mapped by in situ hybridization to human chromosome 3q27-q28." In Drosophila nzelanogaster, mutations in an eye-specific diacylglycerol hnase have been shown to be associated with retinal degene~-i1ti~n.23 Mutational analysis of DAGK3 in 19 unrelated German OPAl patients, however, did not reveal any disease-associated mutations." In addition, the HRYgene, which encodes a basic helix-loop-helix protein, also maps to chromosome 3q28-q29; however, Votruba et al.'4 described recombinations between HRY and OPAl, thereby excluding it as a candidate gene.
Identification of genetic mutations and other genetic and environmental factors involved in dominant optic atrophy, will help to explain the clinical and gender variability observed in affected individuals through phenotype:genotype correlation. This information will also contribute to our understanding of the pathogenesis of autosomal dominant optic atrophy, possibly permitting development of future effective therapies for the disease.
